ClinicalTrials.gov record
Completed Phase 2 Interventional

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

ClinicalTrials.gov ID: NCT00357630

Public ClinicalTrials.gov record NCT00357630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 6:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Protocol: Gemcitabine for Metastatic Cancer With Unknown Primary Site - Analysis of Symptom Benefit

Study identification

NCT ID
NCT00357630
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
52 participants

Conditions and interventions

Interventions

  • gemcitabine hydrochloride Drug
  • quality-of-life assessment Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Jan 31, 2007
Completion
Not listed
Last update posted
Nov 1, 2020

Started 2006

United States locations

U.S. sites
37
U.S. states
8
U.S. cities
27
Facility City State ZIP Site status
University of Illinois Cancer Center Chicago Illinois 60612-7243
Veterans Affairs Medical Center - Chicago Westside Hospital Chicago Illinois 60612
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526
Hinsdale Hematology Oncology Associates Hinsdale Illinois 60521
Regional Cancer Center at Memorial Medical Center Springfield Illinois 62781-0001
Elkhart General Hospital Elkhart Indiana 46515
Howard Community Hospital Kokomo Indiana 46904
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Memorial Hospital of South Bend South Bend Indiana 46601
Saint Joseph Regional Medical Center South Bend Indiana 46617
McFarland Clinic, PC Ames Iowa 50010
Borgess Medical Center Kalamazoo Michigan 49001
West Michigan Cancer Center Kalamazoo Michigan 49007-3731
Bronson Methodist Hospital Kalamazoo Michigan 49007
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton New Jersey 08053
Fox Chase Virtua Health Cancer Program at Virtua West Jersey Voorhees Township New Jersey 08043
Our Lady of Mercy Medical Center Comprehensive Cancer Center The Bronx New York 10466
Mercy Cancer Center at Mercy Medical Center Canton Ohio 44708
Adena Regional Medical Center Chillicothe Ohio 45601
Case Comprehensive Cancer Center Cleveland Ohio 44106-5065
Riverside Methodist Hospital Cancer Care Columbus Ohio 43214-3998
CCOP - Columbus Columbus Ohio 43215
Grant Medical Center Cancer Care Columbus Ohio 43215
Mount Carmel Health - West Hospital Columbus Ohio 43222
Doctors Hospital at Ohio Health Columbus Ohio 43228
Grady Memorial Hospital Delaware Ohio 43015
Fairfield Medical Center Lancaster Ohio 43130
St. Rita's Medical Center Lima Ohio 45801
Strecker Cancer Center at Marietta Memorial Hospital Marietta Ohio 45750
Licking Memorial Cancer Care Program at Licking Memorial Hospital Newark Ohio 43055
Mercy Medical Center Springfield Ohio 45504
Community Hospital of Springfield and Clark County Springfield Ohio 45505
Mount Carmel St. Ann's Cancer Center Westerville Ohio 43081
Genesis - Good Samaritan Hospital Zanesville Ohio 43701
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00357630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2020 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00357630 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →